[1]
McGrogan A, Franssen CF, de Vries CS. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2011 Feb:26(2):414-30. doi: 10.1093/ndt/gfq665. Epub 2010 Nov 10
[PubMed PMID: 21068142]
Level 1 (high-level) evidence
[2]
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group., KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney international. 2021 Oct;
[PubMed PMID: 34556256]
Level 1 (high-level) evidence
[3]
Rosenberg AZ,Kopp JB, Focal Segmental Glomerulosclerosis. Clinical journal of the American Society of Nephrology : CJASN. 2017 Mar 7;
[PubMed PMID: 28242845]
[4]
Shabaka A,Tato Ribera A,Fernández-Juárez G, Focal Segmental Glomerulosclerosis: State-of-the-Art and Clinical Perspective. Nephron. 2020;
[PubMed PMID: 32721952]
Level 3 (low-level) evidence
[5]
Wiggins RC, The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney international. 2007 Jun
[PubMed PMID: 17410103]
[6]
D'Agati VD,Fogo AB,Bruijn JA,Jennette JC, Pathologic classification of focal segmental glomerulosclerosis: a working proposal. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2004 Feb
[PubMed PMID: 14750104]
[7]
Freedman BI,Hicks PJ,Bostrom MA,Cunningham ME,Liu Y,Divers J,Kopp JB,Winkler CA,Nelson GW,Langefeld CD,Bowden DW, Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney international. 2009 Apr;
[PubMed PMID: 19177153]
[8]
Savin VJ,Sharma M,Zhou J,Gennochi D,Fields T,Sharma R,McCarthy ET,Srivastava T,Domen J,Tormo A,Gauchat JF, Renal and Hematological Effects of CLCF-1, a B-Cell-Stimulating Cytokine of the IL-6 Family. Journal of immunology research. 2015
[PubMed PMID: 26146641]
[9]
Delville M,Sigdel TK,Wei C,Li J,Hsieh SC,Fornoni A,Burke GW,Bruneval P,Naesens M,Jackson A,Alachkar N,Canaud G,Legendre C,Anglicheau D,Reiser J,Sarwal MM, A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation. Science translational medicine. 2014 Oct 1
[PubMed PMID: 25273097]
[10]
Königshausen E,Sellin L, Circulating Permeability Factors in Primary Focal Segmental Glomerulosclerosis: A Review of Proposed Candidates. BioMed research international. 2016
[PubMed PMID: 27200372]
[11]
Yu H,Artomov M,Brähler S,Stander MC,Shamsan G,Sampson MG,White JM,Kretzler M,Miner JH,Jain S,Winkler CA,Mitra RD,Kopp JB,Daly MJ,Shaw AS, A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis. The Journal of clinical investigation. 2016 Apr 1
[PubMed PMID: 26927868]
[13]
Han MH,Kim YJ, Practical Application of Columbia Classification for Focal Segmental Glomerulosclerosis. BioMed research international. 2016;
[PubMed PMID: 27247945]
[14]
Markowitz GS,Appel GB,Fine PL,Fenves AZ,Loon NR,Jagannath S,Kuhn JA,Dratch AD,D'Agati VD, Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. Journal of the American Society of Nephrology : JASN. 2001 Jun
[PubMed PMID: 11373339]
[15]
Petersen CE,Amaral S,Frosch E, Lithium-induced nephrotic syndrome in a prepubertal boy. Journal of child and adolescent psychopharmacology. 2008 Apr
[PubMed PMID: 18439118]
[16]
Letavernier E,Bruneval P,Mandet C,Duong Van Huyen JP,Péraldi MN,Helal I,Noël LH,Legendre C, High sirolimus levels may induce focal segmental glomerulosclerosis de novo. Clinical journal of the American Society of Nephrology : CJASN. 2007 Mar
[PubMed PMID: 17699432]
[17]
Crosson JT, Focal segmental glomerulosclerosis and renal transplantation. Transplantation proceedings. 2007 Apr;
[PubMed PMID: 17445586]
[18]
Gong R,Wang P,Dworkin L, What we need to know about the effect of lithium on the kidney. American journal of physiology. Renal physiology. 2016 Dec 1;
[PubMed PMID: 27122541]
[19]
Meehan SM,Kim L,Chang A, A spectrum of morphologic lesions of focal segmental glomerulosclerosis by Columbia criteria in human immunodeficiency virus infection. Virchows Archiv : an international journal of pathology. 2012 Apr
[PubMed PMID: 22388441]
[20]
Chandra P,Kopp JB, Viruses and collapsing glomerulopathy: a brief critical review. Clinical kidney journal. 2013 Feb
[PubMed PMID: 23372939]
[21]
Muehlig AK,Gies S,Huber TB,Braun F, Collapsing Focal Segmental Glomerulosclerosis in Viral Infections. Frontiers in immunology. 2021;
[PubMed PMID: 35095882]
[22]
Brenner BM,Mackenzie HS, Nephron mass as a risk factor for progression of renal disease. Kidney international. Supplement. 1997 Dec
[PubMed PMID: 9407439]
[23]
Kriz W,Lemley KV, Mechanical challenges to the glomerular filtration barrier: adaptations and pathway to sclerosis. Pediatric nephrology (Berlin, Germany). 2017 Mar
[PubMed PMID: 27008645]
[24]
Verani RR, Obesity-associated focal segmental glomerulosclerosis: pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia. American journal of kidney diseases : the official journal of the National Kidney Foundation. 1992 Dec;
[PubMed PMID: 1462993]
[25]
Sim JJ,Batech M,Hever A,Harrison TN,Avelar T,Kanter MH,Jacobsen SJ, Distribution of Biopsy-Proven Presumed Primary Glomerulonephropathies in 2000-2011 Among a Racially and Ethnically Diverse US Population. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2016 Oct
[PubMed PMID: 27138468]
[26]
Kitiyakara C,Eggers P,Kopp JB, Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2004 Nov
[PubMed PMID: 15492947]
[27]
Kopp JB,Nelson GW,Sampath K,Johnson RC,Genovese G,An P,Friedman D,Briggs W,Dart R,Korbet S,Mokrzycki MH,Kimmel PL,Limou S,Ahuja TS,Berns JS,Fryc J,Simon EE,Smith MC,Trachtman H,Michel DM,Schelling JR,Vlahov D,Pollak M,Winkler CA, APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. Journal of the American Society of Nephrology : JASN. 2011 Nov;
[PubMed PMID: 21997394]
[28]
Del Rio M,Kaskel F, Evaluation and management of steroid-unresponsive nephrotic syndrome. Current opinion in pediatrics. 2008 Apr;
[PubMed PMID: 18332710]
Level 3 (low-level) evidence
[29]
Deegens JK,Wetzels JF, Immunosuppressive treatment of focal segmental glomerulosclerosis: lessons from a randomized controlled trial. Kidney international. 2011 Oct;
[PubMed PMID: 21960168]
Level 1 (high-level) evidence
[30]
Kriz W,Lemley KV, A potential role for mechanical forces in the detachment of podocytes and the progression of CKD. Journal of the American Society of Nephrology : JASN. 2015 Feb
[PubMed PMID: 25060060]
[31]
Kriz W,Gretz N,Lemley KV, Progression of glomerular diseases: is the podocyte the culprit? Kidney international. 1998 Sep
[PubMed PMID: 9734594]
[32]
Barisoni L,Schnaper HW,Kopp JB, Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy. Archives of pathology
[PubMed PMID: 19195964]
Level 3 (low-level) evidence
[34]
Gribouval O,Boyer O,Knebelmann B,Karras A,Dantal J,Fourrage C,Alibeu O,Hogan J,Dossier C,Tête MJ,Antignac C,Servais A, APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestries. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2019 Nov 1;
[PubMed PMID: 29992269]
[35]
McCarthy ET,Sharma M,Savin VJ, Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clinical journal of the American Society of Nephrology : CJASN. 2010 Nov;
[PubMed PMID: 20966123]
[36]
Stokes MB,D'Agati VD, Morphologic variants of focal segmental glomerulosclerosis and their significance. Advances in chronic kidney disease. 2014 Sep
[PubMed PMID: 25168828]
Level 3 (low-level) evidence
[37]
Thomas DB,Franceschini N,Hogan SL,Ten Holder S,Jennette CE,Falk RJ,Jennette JC, Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney international. 2006 Mar
[PubMed PMID: 16518352]
[38]
Stokes MB,Markowitz GS,Lin J,Valeri AM,D'Agati VD, Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Kidney international. 2004 May
[PubMed PMID: 15086908]
[39]
Stokes MB,Valeri AM,Markowitz GS,D'Agati VD, Cellular focal segmental glomerulosclerosis: Clinical and pathologic features. Kidney international. 2006 Nov
[PubMed PMID: 17021605]
[40]
Moudgil A,Nast CC,Bagga A,Wei L,Nurmamet A,Cohen AH,Jordan SC,Toyoda M, Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney international. 2001 Jun
[PubMed PMID: 11380814]
[41]
Tomlinson L,Boriskin Y,McPhee I,Holwill S,Rice P, Acute cytomegalovirus infection complicated by collapsing glomerulopathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2003 Jan
[PubMed PMID: 12480980]
[42]
Markowitz GS,Nasr SH,Stokes MB,D'Agati VD, Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis. Clinical journal of the American Society of Nephrology : CJASN. 2010 Apr
[PubMed PMID: 20203164]
[43]
Baradhi KM,Gary Abuelo J,Stillman IE, The Case: diabetic nephropathy in a nondiabetic smoker? Kidney international. 2012 Nov
[PubMed PMID: 23128123]
Level 3 (low-level) evidence
[44]
Guruswamy Sangameswaran KD, Hashmi MF, Baradhi KM. Focal Segmental Glomerulosclerosis. StatPearls. 2023 Jan:():
[PubMed PMID: 30335305]
[45]
Rüster C,Wolf G, The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases. Seminars in nephrology. 2013 Jan
[PubMed PMID: 23374893]
[46]
Chen YM,Liapis H, Focal segmental glomerulosclerosis: molecular genetics and targeted therapies. BMC nephrology. 2015 Jul 9
[PubMed PMID: 26156092]
[47]
Winston JA,Burns GC,Klotman PE, The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy. Seminars in nephrology. 1998 Jul;
[PubMed PMID: 9692350]
[48]
Hogan JJ, A Case of Focal Segmental Glomerulosclerosis. Clinical journal of the American Society of Nephrology : CJASN. 2021 Aug;
[PubMed PMID: 33687967]
Level 3 (low-level) evidence
[49]
Banfi G,Moriggi M,Sabadini E,Fellin G,D'Amico G,Ponticelli C, The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clinical nephrology. 1991 Aug
[PubMed PMID: 1934660]
Level 2 (mid-level) evidence
[50]
Cattran DC,Appel GB,Hebert LA,Hunsicker LG,Pohl MA,Hoy WE,Maxwell DR,Kunis CL, A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney international. 1999 Dec
[PubMed PMID: 10594798]
Level 1 (high-level) evidence
[51]
Fornoni A,Sageshima J,Wei C,Merscher-Gomez S,Aguillon-Prada R,Jauregui AN,Li J,Mattiazzi A,Ciancio G,Chen L,Zilleruelo G,Abitbol C,Chandar J,Seeherunvong W,Ricordi C,Ikehata M,Rastaldi MP,Reiser J,Burke GW 3rd, Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Science translational medicine. 2011 Jun 1
[PubMed PMID: 21632984]
[52]
Nagai R,Cattran DC,Pei Y, Steroid therapy and prognosis of focal segmental glomerulosclerosis in the elderly. Clinical nephrology. 1994 Jul;
[PubMed PMID: 7923961]
[53]
Troyanov S,Wall CA,Miller JA,Scholey JW,Cattran DC, Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. Journal of the American Society of Nephrology : JASN. 2005 Apr
[PubMed PMID: 15716334]
[54]
Costello R,Patel R,Humphreys J,McBeth J,Dixon WG, Patient perceptions of glucocorticoid side effects: a cross-sectional survey of users in an online health community. BMJ open. 2017 Apr 3
[PubMed PMID: 28373256]
Level 2 (mid-level) evidence
[55]
Ramachandran R,Kumar V,Rathi M,Nada R,Jha V,Gupta KL,Sakhuja V,Kohli HS, Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2014 Oct
[PubMed PMID: 24771498]
[56]
Canetta PA,Radhakrishnan J, Impact of the National Institutes of Health Focal Segmental Glomerulosclerosis (NIH FSGS) clinical trial on the treatment of steroid-resistant FSGS. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2013 Mar
[PubMed PMID: 23248028]
[57]
Chun MJ,Korbet SM,Schwartz MM,Lewis EJ, Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. Journal of the American Society of Nephrology : JASN. 2004 Aug
[PubMed PMID: 15284302]
[58]
Li SJ,Tu YM,Zhou CS,Zhang LH,Liu ZH, Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome. Clinical and experimental nephrology. 2016 Apr;
[PubMed PMID: 26220221]
[59]
Zhang Q,Zeng C,Cheng Z,Xie K,Zhang J,Liu Z, Primary focal segmental glomerulosclerosis in nephrotic patients: common complications and risk factors. Journal of nephrology. 2012 Sep-Oct;
[PubMed PMID: 22009935]
[60]
Benz K,Amann K,Dittrich K,Dötsch J, Thrombotic microangiopathy as a complication in a patient with focal segmental glomerulosclerosis. Pediatric nephrology (Berlin, Germany). 2007 Dec;
[PubMed PMID: 17882457]
[61]
Matz EL,Hsieh MH, Review of Advances in Uroprotective Agents for Cyclophosphamide- and Ifosfamide-induced Hemorrhagic Cystitis. Urology. 2017 Feb
[PubMed PMID: 27566144]
Level 3 (low-level) evidence
[62]
Lauritano D,Palmieri A,Lucchese A,Di Stasio D,Moreo G,Carinci F, Role of Cyclosporine in Gingival Hyperplasia: An In Vitro Study on Gingival Fibroblasts. International journal of molecular sciences. 2020 Jan 16
[PubMed PMID: 31963361]
[63]
Meena J,Bagga A, Current Perspectives in Management of Edema in Nephrotic Syndrome. Indian journal of pediatrics. 2020 Aug
[PubMed PMID: 32232733]
Level 3 (low-level) evidence